Model membrane approaches to determine the role of calcium for the antimicrobial activity of friulimicin

International Journal of Antimicrobial Agents

Volumn 37, Issue 3, 2011, Pages 256-260

  Reder Christ, Katrin ^a   Falkenstein Paul, Hildegard ^a   Klocek, Gabriela ^b   Al Kaddah, Saad ^a   Bakowsky, Udo ^c   Bendas, Gerd ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Antibiotic cyclic lipopeptides; Atomic force microscopy; Biosensor; C 55 P; Friulimicin

Indexed keywords

CALCIUM; FRIULIMICIN B; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; ARTIFICIAL MEMBRANE; BINDING AFFINITY; CONTROLLED STUDY; DRUG CONFORMATION; DRUG STRUCTURE; DRUG TARGETING; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BIOSENSING TECHNIQUES; CALCIUM; CELL MEMBRANE; CELL WALL; CIRCULAR DICHROISM; DRUG DISCOVERY; GRAM-POSITIVE BACTERIA; MICROSCOPY, ATOMIC FORCE; MOLECULAR STRUCTURE; PEPTIDES; POLYISOPRENYL PHOSPHATES; PROTEIN CONFORMATION; SPECTRUM ANALYSIS;

EID: 79951956615     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.11.024     Document Type: Article

References (12)

1. L. Vértesy, E. Ehlers, H. Kogler, M. Kurz, J. Meiwes, and G. Seibert Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. II. Isolation and structural characterization J Antibiot (Tokyo) 53 2000 816 827
2. P. Bemer, M.E. Juvin, A. Bryskier, and H. Drugeon In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant Gram-positive isolates Antimicrob Agents Chemother 47 2003 3025 3029 (Pubitemid 37040294)
3. R.H. Baltz, V. Miao, and S.K. Wrigley Natural products to drugs: daptomycin and related lipopeptide antibiotics Nat Prod Rep 22 2005 717 741 (Pubitemid 41830839)
4. J.A. Silverman, N.G. Perlmutter, and H.M. Shapiro Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus Antimicrob Agents Chemother 47 2003 2538 2544 (Pubitemid 36919456)
5. S.K. Straus, and R.E. Hancock Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides Biochim Biophys Acta 1758 2006 1215 1223 (Pubitemid 44436068)
6. T. Wecke, D. Zühlke, U. Mäder, S. Jordan, B. Voigt, and S. Pelzer Daptomycin versus friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses Antimicrob Agents Chemother 53 2009 1619 1623
7. T. Schneider, K. Gries, M. Josten, I. Wiedemann, S. Pelzer, and H. Labischinski The lipopeptide antibiotic friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate Antimicrob Agents Chemother 53 2009 1610 1618
8. K. Christ, H.H. Rüttinger, M. Höpfner, U. Rothe, and G. Bendas The detection of UV-induced membrane damages by a combination of two biosensor techniques Photochem Photobiol 81 2005 1417 1423 (Pubitemid 43035853)
9. K. Christ, I. Wiedemann, U. Bakowsky, H.G. Sahl, and G. Bendas The role of lipid II in membrane binding of and pore formation by nisin analyzed by two combined biosensor techniques Biochim Biophys Acta 1768 2007 694 704 (Pubitemid 46275601)
10. L. Smith, N.J. Greenfield, and S.E. Hitchcock-DeGregori The effects of deletion of the amino-terminal helix on troponin C function and stability J Biol Chem 269 1994 9857 9863 (Pubitemid 24196595)
11. D. Jung, A. Rozek, M. Okon, and R.E. Hancock Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin Chem Biol 11 2004 949 957 (Pubitemid 38991789)
12. S.W. Ho, D. Jung, J.R. Calhoun, J.D. Lear, M. Okon, and W.R.P. Scott Effect of divalent cations on the structure of the antibiotic daptomycin Eur Biophys J 37 2008 421 433 (Pubitemid 351423116)